GlobeNewswire·Aug 10, 2026, 11:00 AM ET

Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)

Zealand Pharma A/S reported share buy-back transactions executed on Nasdaq Copenhagen during week 32 (August 3–7, 2026) under its program announced on May 7, 2026.
The program allows the company to repurchase shares up to a total consideration of DKK 1.3 billion, with a maximum of 7,152,557 shares, running from May 7, 2026, to October 31, 2026.
Danske Bank acts as the independent lead manager for the program, making its own trading decisions without company influence.
During week 32, the company acquired 131,000 shares at an average price of DKK 321.40, totaling a transaction value of DKK 42,102,200.
Specific weekly transaction details include 28,000 shares on August 3 at DKK 306.71, 27,000 shares on August 4 at DKK 315.86, 27,000 shares on August 5 at DKK 320.68, 27,000 shares on August 6 at DKK 328.90, 22,000 shares on August 7 at DKK 338.52.
Total accumulated shares under the program now stand at 2,470,000 with a cumulative value of DKK 741,654,000.
Following these transactions, Zealand Pharma holds 3,340,482 treasury shares, representing approximately 4.66% of its total share capital of 71,578,758 shares.
Each share has a nominal value of DKK 1.